Skip to content
LexBuild

Foreign-Trade Zone (FTZ) 76-Danbury, Connecticut; Authorization of Production Activity; MannKind Corporation (Fumaryl Diketopiperazone (FDKP) Carrier/Receptor Powder), Danbury, Connecticut 

---
identifier: "/us/fr/2017-12411"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Foreign-Trade Zone (FTZ) 76-Danbury, Connecticut; Authorization of Production Activity; MannKind Corporation (Fumaryl Diketopiperazone (FDKP) Carrier/Receptor Powder), Danbury, Connecticut"
title_number: 0
title_name: "Federal Register"
section_number: "2017-12411"
section_name: "Foreign-Trade Zone (FTZ) 76-Danbury, Connecticut; Authorization of Production Activity; MannKind Corporation (Fumaryl Diketopiperazone (FDKP) Carrier/Receptor Powder), Danbury, Connecticut"
positive_law: false
currency: "2017-06-15"
last_updated: "2017-06-15"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Commerce Department"
document_number: "2017-12411"
document_type: "notice"
publication_date: "2017-06-15"
agencies:
  - "Commerce Department"
  - "Foreign-Trade Zones Board"
fr_citation: "82 FR 27465"
fr_volume: 82
docket_ids:
  - "B-85-2016"
---

#  Foreign-Trade Zone (FTZ) 76—Danbury, Connecticut; Authorization of Production Activity; MannKind Corporation (Fumaryl Diketopiperazone (FDKP) Carrier/Receptor Powder), Danbury, Connecticut

On December 21, 2016, MannKind Corporation submitted a notification of proposed production activity to the FTZ Board for its facility within FTZ Subzone 76B, in Danbury, Connecticut.

The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the *Federal Register* inviting public comment (82 FR 1689, January 6, 2017). On April 20, 2017, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.

Dated: June 8, 2017.

Andrew McGilvray,

Executive Secretary.